These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31434754)

  • 1. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A.
    Samaranch L; Pérez-Cañamás A; Soto-Huelin B; Sudhakar V; Jurado-Arjona J; Hadaczek P; Ávila J; Bringas JR; Casas J; Chen H; He X; Schuchman EH; Cheng SH; Forsayeth J; Bankiewicz KS; Ledesma MD
    Sci Transl Med; 2019 Aug; 11(506):. PubMed ID: 31434754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A.
    Bu J; Ashe KM; Bringas J; Marshall J; Dodge JC; Cabrera-Salazar MA; Forsayeth J; Schuchman EH; Bankiewicz KS; Cheng SH; Shihabuddin LS; Passini MA
    Mol Ther; 2012 Oct; 20(10):1893-901. PubMed ID: 22828503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.
    Salegio EA; Samaranch L; Jenkins RW; Clarke CJ; Lamarre C; Beyer J; Kells AP; Bringas J; Sebastian WS; Richardson RM; Rosenbluth KH; Hannun YA; Bankiewicz KS; Forsayeth J
    Hum Gene Ther; 2012 Aug; 23(8):891-902. PubMed ID: 22574943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
    Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
    Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse.
    Passini MA; Bu J; Fidler JA; Ziegler RJ; Foley JW; Dodge JC; Yang WW; Clarke J; Taksir TV; Griffiths DA; Zhao MA; O'Riordan CR; Schuchman EH; Shihabuddin LS; Cheng SH
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9505-10. PubMed ID: 17517638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.
    Passini MA; Macauley SL; Huff MR; Taksir TV; Bu J; Wu IH; Piepenhagen PA; Dodge JC; Shihabuddin LS; O'Riordan CR; Schuchman EH; Stewart GR
    Mol Ther; 2005 May; 11(5):754-62. PubMed ID: 15851014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
    Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.
    Salegio EA; Kells AP; Richardson RM; Hadaczek P; Forsayeth J; Bringas J; Sardi SP; Passini MA; Shihabuddin LS; Cheng SH; Fiandaca MS; Bankiewicz KS
    Hum Gene Ther; 2010 Sep; 21(9):1093-103. PubMed ID: 20408734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease.
    Schuchman EH
    J Inherit Metab Dis; 2007 Oct; 30(5):654-63. PubMed ID: 17632693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
    Ledesma MD; Prinetti A; Sonnino S; Schuchman EH
    J Neurochem; 2011 Mar; 116(5):779-88. PubMed ID: 21214563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleged Detrimental Mutations in the SMPD1 Gene in Patients with Niemann-Pick Disease.
    Rhein C; Mühle C; Kornhuber J; Reichel M
    Int J Mol Sci; 2015 Jun; 16(6):13649-52. PubMed ID: 26084044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
    Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
    J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.
    Hollak CE; de Sonnaville ES; Cassiman D; Linthorst GE; Groener JE; Morava E; Wevers RA; Mannens M; Aerts JM; Meersseman W; Akkerman E; Niezen-Koning KE; Mulder MF; Visser G; Wijburg FA; Lefeber D; Poorthuis BJ
    Mol Genet Metab; 2012 Nov; 107(3):526-33. PubMed ID: 22818240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
    Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
    Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
    Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
    J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A.
    Gabandé-Rodríguez E; Boya P; Labrador V; Dotti CG; Ledesma MD
    Cell Death Differ; 2014 Jun; 21(6):864-75. PubMed ID: 24488099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
    Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
    Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types A and B Niemann-Pick Disease.
    Schuchman EH; Wasserstein MP
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():674-81. PubMed ID: 27491215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A.
    Long Y; Xu M; Li R; Dai S; Beers J; Chen G; Soheilian F; Baxa U; Wang M; Marugan JJ; Muro S; Li Z; Brady R; Zheng W
    Stem Cells Transl Med; 2016 Dec; 5(12):1644-1655. PubMed ID: 27484861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.